Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders-Reference-Cited by-同舟云学术

Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders

Published:2016-05 Issue:5 Volume:22 Page:895-901
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Klein Orly R.,Chen Allen R.,Gamper Christopher,Loeb David,Zambidis Elias,Llosa Nicolas,Huo Jeffrey,Dezern Amy E.,Steppan Diana,Robey Nancy,Holuba Mary Jo^ORCID,Cooke Kenneth R.,Symons Heather J.

Funder

Giant Food Children's Cancer Research Fund

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review;Mateos;Pediatr Blood Cancer,2013

2. Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution;Brissot;Bone Marrow Transplant,2016

3. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;N Engl J Med,2014

4. Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen

5. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia;Marsh;Blood,2011

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity;Blood;2024-08-01

2. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders;International Journal of Molecular Sciences;2024-06-09

3. The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia;Pediatric Transplantation;2024-05-20

4. Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China;Clinical Immunology;2024-03

5. Hematopoietic Stem Cell Transplantation for Inborn Errors of Immunity in Children;Comprehensive Hematology and Stem Cell Research;2024